Cellectis S.A.
CLLS
$3.62
$0.123.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -70.44% | 110.30% | |||
| Total Other Revenue | -9.14% | 35.60% | |||
| Total Revenue | -67.15% | 104.27% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -67.15% | 104.27% | |||
| SG&A Expenses | -7.80% | 2.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 307.79% | 59.26% | |||
| Total Operating Expenses | 1.49% | 4.83% | |||
| Operating Income | -315.78% | 183.88% | |||
| Income Before Tax | -4,640.07% | 102.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4,568.25% | 102.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4,568.25% | 102.48% | |||
| EBIT | -315.78% | 183.88% | |||
| EBITDA | -237.28% | 272.86% | |||
| EPS Basic | -4,545.76% | 102.46% | |||
| Normalized Basic EPS | -4,602.70% | 102.47% | |||
| EPS Diluted | -4,545.76% | 102.46% | |||
| Normalized Diluted EPS | -4,727.78% | 102.40% | |||
| Average Basic Shares Outstanding | 0.00% | 1.44% | |||
| Average Diluted Shares Outstanding | -1.36% | 2.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||